Early trials demonstrate that Retatrutide – a dual stimulator of gut hormone and glucose-dependent insulinotropic polypeptide receptors – offers a substantial advance in weight management therapies. In contrast to existing medications , the peptide seems to affect appetite and calorie expenditure by means of separate pathways . While more copy